|
CCDC88B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.467000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.701800E-01 |
| Normal-vs-Stage2 |
4.163000E-01 |
| Normal-vs-Stage3 |
8.020600E-01 |
| Normal-vs-Stage4 |
6.281000E-01 |
| Stage1-vs-Stage2 |
4.118400E-01 |
| Stage1-vs-Stage3 |
6.782600E-01 |
| Stage1-vs-Stage4 |
8.658000E-01 |
| Stage2-vs-Stage3 |
2.895000E-01 |
| Stage2-vs-Stage4 |
5.549600E-01 |
| Stage3-vs-Stage4 |
6.498600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.457800E-01 |
| Normal-vs-AfricanAmerican |
5.491000E-01 |
| Normal-vs-Asian |
6.544000E-01 |
| Caucasian-vs-AfricanAmerican |
5.261800E-01 |
| Caucasian-vs-Asian |
7.272400E-01 |
| AfricanAmerican-vs-Asian |
7.487600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.963200E-01 |
| Normal-vs-Female |
5.983800E-01 |
| Male-vs-Female |
4.558400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.486000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.669800E-01 |
| Normal-vs-Age(61-80Yrs) |
7.947800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.986000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.789200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.990200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.231800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.412800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.114240E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.916200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.260600E-01 |
| Classical-VS-Follicular |
6.885600E-01 |
| Classical-VS-Other |
9.336400E-01 |
| Classical-VS-Normal |
5.907600E-01 |
| Tall-VS-Follicular |
5.276400E-01 |
| Tall-VS-Other |
7.645000E-01 |
| Tall-VS-Normal |
9.213200E-01 |
| Follicular-VS-Other |
9.681200E-01 |
| Follicular-VS-Normal |
5.081000E-01 |
| Other-VS-Normal |
6.260000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.636000E-01 |
| Normal-vs-N1 |
5.190200E-01 |
| N0-vs-N1 |
2.513600E-01 |
|
|
